Greg Miller

Biography

Greg Miller has more than a decade of pharmaceutical business development experience and has established partnerships in the biopharmaceutical industry generating more than $100 million in upfront payments and over $1.5 billion in potential future milestones. Prior to joining Visterra, Mr. Miller served as Vice President of Business and Corporate Development at Concert Pharmaceuticals where he secured numerous collaborations related to the company's drug development platform, including transactions with Avanir Pharmaceuticals, Jazz Pharmaceuticals, and Celgene Corporation. Previously, he was Senior Director of Business Development and Corporate Strategy at AMAG Pharmaceuticals where he led the efforts in establishing a multi-regional partnership with Takeda Pharmaceuticals. Mr. Miller began his pharmaceutical career at Genzyme Corporation in 2002, where he held various roles in business development, licensing, marketing, and reimbursement. He holds a BA in Psychology from Brandeis University, and both an MBA and an MPH from Boston University.

Research Interest

Medicine and Pharmaceutical